SCHEMBL27759367

SCHEMBL27759367

O=CNNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172838 0.91
SCHEMBL3173876 0.88 ADH1B (0.59)
SCHEMBL27758272 0.88
SCHEMBL23845317 0.88 ADH1B (0.59)
SCHEMBL13548254 0.80 CA12 (0.39)
SCHEMBL27660973 0.78 KDM4E (0.36)
SCHEMBL7459706 0.73 ALDH1A1 (0.36)
SCHEMBL27936411 0.73
SCHEMBL28286922 0.70 ADH1B (0.41)
SCHEMBL19658308 0.67 ADH1B (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101541348-A Hydrazone derivatives and use thereof LINGUAGEN CORP (US) 2009-09-23 CN claimed
CN-109071492-A Azabicyclo-substituted triazole derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2018-12-21 CN disclosed
CN-101541348-A Hydrazone derivatives and use thereof LINGUAGEN CORP (US) 2009-09-23 CN disclosed